Statistical framework for gene expression data analysis
- PMID: 17634612
- DOI: 10.1007/978-1-59745-390-5_6
Statistical framework for gene expression data analysis
Abstract
DNA (mRNA) microarray, a highly promising technique with a variety of applications, can yield a wealth of data about each sample, well beyond the reach of every individual's comprehension. A need exists for statistical approaches that reliably eliminate insufficient and uninformative genes (probe sets) from further analysis while keeping all essentially important genes. This procedure does call for in-depth knowledge of the biological system to analyze. We conduct a comparative study of several statistical approaches on our own breast cancer Affymetrix microarray datasets. The strategy is designed primarily as a filter to select subsets of genes relevant for classification. We outline a general framework based on different statistical algorithms for determining a high-performing multigene predictor of response to the preoperative treatment of patients. We hope that our approach will provide straightforward and useful practical guidance for identification of genes, which can discriminate between biologically relevant classes in microarray datasets.
Similar articles
-
Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.BJU Int. 2011 Jul;108(2 Pt 2):E29-35. doi: 10.1111/j.1464-410X.2010.09794.x. Epub 2011 Mar 16. BJU Int. 2011. PMID: 21435154
-
Filter versus wrapper gene selection approaches in DNA microarray domains.Artif Intell Med. 2004 Jun;31(2):91-103. doi: 10.1016/j.artmed.2004.01.007. Artif Intell Med. 2004. PMID: 15219288 Review.
-
Gene selection and classification from microarray data using kernel machine.FEBS Lett. 2004 Jul 30;571(1-3):93-8. doi: 10.1016/j.febslet.2004.05.087. FEBS Lett. 2004. PMID: 15280023
-
A framework to identify physiological responses in microarray-based gene expression studies: selection and interpretation of biologically relevant genes.Physiol Genomics. 2008 Mar 14;33(1):78-90. doi: 10.1152/physiolgenomics.00167.2007. Epub 2007 Dec 27. Physiol Genomics. 2008. PMID: 18162501
-
Epirubicin as adjuvant therapy in breast cancer.Expert Rev Anticancer Ther. 2004 Apr;4(2):189-95. doi: 10.1586/14737140.4.2.189. Expert Rev Anticancer Ther. 2004. PMID: 15056049 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous